Home Pilots Home allergy testing company Nectar secures $16.5M in funding Pilots Home allergy testing company Nectar secures $16.5M in funding By - December 20, 2022 41 0 Facebook Twitter Pinterest WhatsApp The investment will support the company’s growth nationwide, fund clinical trials and open a physical location. RELATED ARTICLESMORE FROM AUTHOR Pilots Medtronic issues voluntary recall of MiniMed insulin pumps Pilots Hybrid primary care company Rezilient Health scores $10M Pilots Empathy Health Technologies raises $2.8M for Sober Sidekick app LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Wolters Kluwer, Unbound Medicine announce mobile drug guide for nurses Pilots - August 2, 2023 0 Signify Health buys fellow value-based care focused company Caravan Health Pilots - February 10, 2022 0 Mindler scoops up Finnish mental health tracker Medified Solutions Oy Pilots - February 22, 2022 0 Orion Health secures HITRUST, DirectTrust accreditations Pilots - February 9, 2023 0 How the digital health industry can innovate and improve health outcomes for all Pilots - January 28, 2022 0 POPULAR CATEGORIESPilots2166Applications750Testing283Collaborations15GitHub3